MXCT
MXCT
NASDAQ · Life Sciences Tools & Services

Maxcyte Inc

$1.27
-0.05 (-3.79%)
As of Aug 18, 10:17 PM ET ·
Financial Highlights (FY 2026)
Revenue
42.11M
Net Income
-56,906,436
Gross Margin
81.2%
Profit Margin
-135.1%
Rev Growth
-9.3%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 81.2% 81.2% 41.4% 41.4%
Operating Margin -157.1% -141.4% 7.9% 8.9%
Profit Margin -135.1% -128.4% 7.9% 6.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 42.11M 46.43M 11.59M 9.98M
Gross Profit 34.18M 37.68M 4.80M 4.13M
Operating Income -66,176,690 -65,665,954 910.9K 885.5K
Net Income -56,906,436 -56,467,246 913.3K 656.0K
Gross Margin 81.2% 81.2% 41.4% 41.4%
Operating Margin -157.1% -141.4% 7.9% 8.9%
Profit Margin -135.1% -128.4% 7.9% 6.6%
Rev Growth -9.3% -9.3% +8.1% +21.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 17.20M 19.69M
Total Equity 38.88M 41.65M
D/E Ratio 0.44 0.47
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -60,787,963 -63,669,862 1.25M 1.22M
Free Cash Flow 402.0K 324.3K